Screening for thrombophilic risk factors among 25 German patients with cerebral venous thrombosis

Objectives– In this study the frequency of inherited thrombophilic risk factors in a population of German CVT patients and their influence on clinical outcome were evaluated. Material and methods– Twenty‐five patients (age 37.1±16.3 years) with CVT were screened for inherited coagulation disorders....

Full description

Saved in:
Bibliographic Details
Published inActa neurologica Scandinavica Vol. 102; no. 1; pp. 31 - 36
Main Authors Stolz, E., Kemkes-Matthes, B., Pötzsch, B., Hahn, M., Kraus, J., Wirbartz, A., Kaps, M.
Format Journal Article
LanguageEnglish
Published Copenhagen Munksgaard International Publishers 01.07.2000
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objectives– In this study the frequency of inherited thrombophilic risk factors in a population of German CVT patients and their influence on clinical outcome were evaluated. Material and methods– Twenty‐five patients (age 37.1±16.3 years) with CVT were screened for inherited coagulation disorders. All participants received a full clinical follow‐up (mean follow‐up period 4.8±6.4 years). Results– Inherited thrombophilic risk factors were identified in 9 (36%) of the 25 patients studied. Four were found positive for the heterozygous factor V Leiden mutation, 2 were heterozygous carriers of the prothrombin‐G20210A‐polymorphism. APC resistance proved to be a reliable screening method for factor V Leiden mutation, whereas genetic evaluation for protein S and C deficiencies failed to demonstrate any mutations despite the identification of 1 patient with a protein C and protein S deficiency each. One patient suffered from a familial plasminogen deficiency. These 9 patients had a less favorable outcome (P<0.05). Conclusion– Our results demonstrate that screening for inherited thrombophilia should be an integral part in the diagnostic work up of CVT patients. Patients with inherited coagulopathies tended to have a less favorable outcome, corroborating recommendations for a longer period of oralanticoagulation.
Bibliography:ark:/67375/WNG-5KM628WB-H
istex:D15992D4AA7E17637CA04B3DA24653E5779F26B6
ArticleID:ane90355a
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0001-6314
1600-0404
DOI:10.1034/j.1600-0404.2000.102001031.x